Production of polyurethane foams
The invention relates to a process for producing polyurethane foams, by frothing and drying mixtures of specific polyurethane dispersions and crosslinkers.
1. A process for producing foamed articles comprising
frothing and drying a composition comprising aqueous polyurethane dispersions (I) anionically hydrophilicized by means of sulphonate groups and a crosslinker (II);
wherein said polyurethane dispersion (I) is prepared by
A) producing a isocyanate-functional prepolymer from
A1) organic polyisocyanates;
A2) polymeric polyols having number-average molecular weights in the range from 400 to 8000 g/mol and OH functionalities in the range from 1.5 to 6; and
A3) optionally hydroxyl-functional compounds having molecular weights in the range from 62 to 399 g/mol; and
A4) optionally isocyanate-reactive, anionic or potentially anionic and optionally nonionic hydrophilicizing agents;
and
B) wholly or partly reacting the free NCO groups of said isocyanate-functional prepolymer
B1) optionally with amino-functional compounds having molecular weights in the range from 32 to 400 g/mol; and
B2) with an alkali metal salt of a mono- or diamino sulphonic acid
by chain extension;
wherein said isocyanate-functional prepolymer is dispersed in water before, during or after step B),
wherein at least partial chemical crosslinking occurs during frothing and/or drying, and wherein said crosslinkers (II) are selected from the group consisting of unblocked, optionally hydrophilicized polyisocyanates; amide- and amine-formaldehyde resins; phenolic resins; aldehyde and ketone resins; resols; furan resins; urea resins; carbamidic ester resins; triazine resins; melamine resins; benzoguanamine resins; cyanamide resins; and aniline resins, and
wherein the foamed article is a wound dressing.
2. The process of claim 1 , wherein said polyurethane dispersion (I) are anionically hydrophilicized by sulphonate groups only.
3. The process of claim 2 , wherein said sulphonate groups have alkali metal cations as counter-ions.
4. The process of claim 1 , wherein said polyurethane dispersion (I) comprise 0.1 to 15 milliequivalents per 100 g of solid resin of anionic or potentially anionic groups based on solid resin.
5. The process of claim 1 , wherein said polyurethane dispersion (I) have solids contents in the range of from 55% to 65% by weight based on the polyurethane present therein.
6. The process of claim 1 , wherein said crosslinkers (II) are unblocked polyisocyanates.
7. The process of claim 6 , wherein said unblocked polyisocyanates are hydrophilicized.
8. The process of claim 1 , further comprising auxiliary and additive materials (III).
9. The process of claim 8 , wherein said auxiliary and additive materials (III) are foam formers and stabilizers selected from the group consisting of fatty acid amides, sulphosuccinamides, hydrocarbyl sulphonates or sulphates, alkyl polyglycosides, EO-PO block copolymers,fatty acid salts, and combinations thereof.
10. The process of claim 9 , wherein said foam formers and stabilizers are EO-PO block copolymers.
11. The process of claim 1 , further comprising active components selected from the group consisting of antiseptics, growth factors, protease inhibitors, and nonsteroidal anti-inflammatories/opiates.
12. The process of claim 11 , wherein said active component is an antiseptic biguanide and/or its salt.
13. A foamed article prepared by the process of claim 1 .
14. The foamed article of claim 13 , wherein said foamed article has a microporous, open-cell structure and a density of below 0.4 g/cm 3 in the dried state.
15. The foamed article of claim 13 , wherein said foamed article has a DIN EN 13726-1 Part 3.2 physiological saline absorbency in the range from 100 to 1500% (mass of liquid taken up, based on the mass of dry foam) and a DIN EN 13726-2 Part 3.2 water vapour transmission rate in the range from 2000 to 8000 g/24 h*m 2 .
16. The foamed article of claim 13 , wherein said foamed article further comprises an active component.
17. The foamed article of claim 13 , wherein said foamed article is a wound dressing.
18. The process of claim 1 , wherein the foamed article has a microporous, open-cell structure and a density of below 0.4 g/cm 3 in the dried state.
19. The process of claim 1 , wherein the foamed article has a DIN EN 13726-1 Part 3.2 physiological saline absorbency in the range from 100 to 1500% (mass of liquid taken up, based on the mass of dry foam) and a DIN EN 13726-2 Part 3.2 water vapour transmission rate in the range from 2000 to 8000 g/24 h*m 2 .
20. The process of claim 1 , wherein the foamed article further comprises an active component.
21. The process of claim 1 , wherein component B2) is selected from the group consisting of salts of 2-(2-aminoethylamino)ethanesulphonic acid, ethylenediaminepropylsulphonic acid, ethylenediaminebutylsulphonic acid, 1,2- or 1,3-propylenediamine-β-ethylsulphonic acid, taurine and salt of cyclohexylaminopropanesulphonic acid.
22. The process of claim 1 , wherein components A1) to A4) and B1) to B2) are used in the following amounts:
10% to 30% by weight of component A1),
65% to 85% by weight of A2),
0.5% to 14% by weight of the sum total of components A3) and B1)
0.1% to 13.5% by weight of the sum total of the components A4) and B2), with 0.5 to 3.0% by weight of anionic or potentially anionic hydrophilicizing agents from A4) and/or B2) being used, based on the total amount of components A1) to A4) and B1) to B2), and wherein the total amounts of A1) to A4) and B1) to B2) do not exceed a 100% by weight.